Morgan Stanley’s Cingulate CING Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.3K Buy
4,263
+1,863
+78% +$9.4K ﹤0.01% 6758
2026
Q1
$14.9K Buy
2,400
+1,400
+140% +$8.94K ﹤0.01% 6829
2025
Q4
$4.34K Buy
+1,000
New +$3.86K ﹤0.01% 7095
2023
Q1
Hold
0
-$19 7730
2022
Q4
Hold
0
7775
2022
Q3
Hold
0
7720

Other funds holding CING

Morgan Stanley's CING Position: Q2 2026 in Review

Morgan Stanley increased its Cingulate (CING) stake by 78% in Q2 2026, buying an estimated $9.4K and bringing the position to 4,263 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6758.

Morgan Stanley first reported a position in CING in Q4 2025 and has held it in 3 quarters since. 33 funds tracked by Wall St. Rank hold CING as of Q2 2026.

  • Morgan Stanley held 4,263 shares of Cingulate worth $23.3K as of Q2 2026.
  • Morgan Stanley bought 1,863 Cingulate shares in Q2 2026, an estimated $9.4K.
  • Cingulate made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6758 holding.
  • Morgan Stanley first reported a position in Cingulate in Q4 2025 and has held it in 3 quarters since.
  • 33 funds tracked by Wall St. Rank held Cingulate as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.